420 related articles for article (PubMed ID: 27454931)
21. Design, synthesis, and biological evaluation of HDAC6 inhibitors targeting L1 loop and serine 531 residue.
Jha S; Kim JH; Kim M; Nguyen AH; Ali KH; Gupta SK; Park SY; Ha E; Seo YH
Eur J Med Chem; 2024 Feb; 265():116057. PubMed ID: 38142511
[TBL] [Abstract][Full Text] [Related]
22. Structural and energetic basis for the inhibitory selectivity of both catalytic domains of dimeric HDAC6.
Sixto-López Y; Bello M; Correa-Basurto J
J Biomol Struct Dyn; 2019 Nov; 37(18):4701-4720. PubMed ID: 30558483
[TBL] [Abstract][Full Text] [Related]
23. A Review of Progress in Histone Deacetylase 6 Inhibitors Research: Structural Specificity and Functional Diversity.
Zhang XH; Qin-Ma ; Wu HP; Khamis MY; Li YH; Ma LY; Liu HM
J Med Chem; 2021 Feb; 64(3):1362-1391. PubMed ID: 33523672
[TBL] [Abstract][Full Text] [Related]
24. Expression and Crystallization of HDAC6 Tandem Catalytic Domains.
Langousis G; Sanchez J; Kempf G; Matthias P
Methods Mol Biol; 2023; 2589():467-480. PubMed ID: 36255643
[TBL] [Abstract][Full Text] [Related]
25. Azetidin-2-one-based small molecules as dual hHDAC6/HDAC8 inhibitors: Investigation of their mechanism of action and impact of dual inhibition profile on cell viability.
Federico S; Khan T; Fontana A; Brogi S; Benedetti R; Sarno F; Carullo G; Pezzotta A; Saraswati AP; Passaro E; Pozzetti L; Papa A; Relitti N; Gemma S; Butini S; Pistocchi A; Ramunno A; Vincenzi F; Varani K; Tatangelo V; Patrussi L; Baldari CT; Saponara S; Gorelli B; Lamponi S; Valoti M; Saccoccia F; Giannaccari M; Ruberti G; Herp D; Jung M; Altucci L; Campiani G
Eur J Med Chem; 2022 Aug; 238():114409. PubMed ID: 35551034
[TBL] [Abstract][Full Text] [Related]
26. Development of First-in-Class Dual Sirt2/HDAC6 Inhibitors as Molecular Tools for Dual Inhibition of Tubulin Deacetylation.
Sinatra L; Vogelmann A; Friedrich F; Tararina MA; Neuwirt E; Colcerasa A; König P; Toy L; Yesiloglu TZ; Hilscher S; Gaitzsch L; Papenkordt N; Zhai S; Zhang L; Romier C; Einsle O; Sippl W; Schutkowski M; Gross O; Bendas G; Christianson DW; Hansen FK; Jung M; Schiedel M
J Med Chem; 2023 Nov; 66(21):14787-14814. PubMed ID: 37902787
[TBL] [Abstract][Full Text] [Related]
27. Multitarget Approach for the Treatment of Alzheimer's Disease: Inhibition of Phosphodiesterase 9 (PDE9) and Histone Deacetylases (HDACs) Covering Diverse Selectivity Profiles.
Rabal O; Sánchez-Arias JA; Cuadrado-Tejedor M; de Miguel I; Pérez-González M; García-Barroso C; Ugarte A; Estella-Hermoso de Mendoza A; Sáez E; Espelosin M; Ursua S; Tan H; Wu W; Xu M; Pineda-Lucena A; Garcia-Osta A; Oyarzabal J
ACS Chem Neurosci; 2019 Sep; 10(9):4076-4101. PubMed ID: 31441641
[TBL] [Abstract][Full Text] [Related]
28. Quinazolin-2,4-dione-Based Hydroxamic Acids as Selective Histone Deacetylase-6 Inhibitors for Treatment of Non-Small Cell Lung Cancer.
Yu CW; Hung PY; Yang HT; Ho YH; Lai HY; Cheng YS; Chern JW
J Med Chem; 2019 Jan; 62(2):857-874. PubMed ID: 30525585
[TBL] [Abstract][Full Text] [Related]
29. Trichostatin A induces Trypanosoma cruzi histone and tubulin acetylation: effects on cell division and microtubule cytoskeleton remodelling.
de Oliveira Santos J; Zuma AA; de Luna Vitorino FN; da Cunha JPC; de Souza W; Motta MCM
Parasitology; 2019 Apr; 146(4):543-552. PubMed ID: 30421693
[TBL] [Abstract][Full Text] [Related]
30. A novel class of anthraquinone-based HDAC6 inhibitors.
Song Y; Lim J; Seo YH
Eur J Med Chem; 2019 Feb; 164():263-272. PubMed ID: 30597327
[TBL] [Abstract][Full Text] [Related]
31. Chemical Versatility in Catalysis and Inhibition of the Class IIb Histone Deacetylases.
Christianson DW
Acc Chem Res; 2024 Apr; 57(8):1135-1148. PubMed ID: 38530703
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and biological evaluation of novel N-benzyltriazolyl-hydroxamate derivatives as selective histone deacetylase 6 inhibitors.
Kong SJ; Nam G; Boggu PR; Park GM; Kang JE; Park HJ; Jung YH
Bioorg Med Chem; 2023 Feb; 79():117154. PubMed ID: 36645952
[TBL] [Abstract][Full Text] [Related]
33. Rutin increases alpha-tubulin acetylation via histone deacetylase 6 inhibition.
Çetin Ö; Sari S; Erdem-Yurter H; Bora G
Drug Dev Res; 2022 Jun; 83(4):993-1002. PubMed ID: 35266183
[TBL] [Abstract][Full Text] [Related]
34. Tektin4 loss promotes triple-negative breast cancer metastasis through HDAC6-mediated tubulin deacetylation and increases sensitivity to HDAC6 inhibitor.
Ge LP; Jin X; Yang YS; Liu XY; Shao ZM; Di GH; Jiang YZ
Oncogene; 2021 Mar; 40(12):2323-2334. PubMed ID: 33654196
[TBL] [Abstract][Full Text] [Related]
35. Involvement of HDAC6 in ischaemia and reperfusion-induced rat retinal injury.
Yuan H; Li H; Yu P; Fan Q; Zhang X; Huang W; Shen J; Cui Y; Zhou W
BMC Ophthalmol; 2018 Nov; 18(1):300. PubMed ID: 30453928
[TBL] [Abstract][Full Text] [Related]
36. Structural Basis of Catalysis and Inhibition of HDAC6 CD1, the Enigmatic Catalytic Domain of Histone Deacetylase 6.
Osko JD; Christianson DW
Biochemistry; 2019 Dec; 58(49):4912-4924. PubMed ID: 31755702
[TBL] [Abstract][Full Text] [Related]
37. Structure-activity relationship study of thiazolyl-hydroxamate derivatives as selective histone deacetylase 6 inhibitors.
Nam G; Jung JM; Park HJ; Baek SY; Baek KS; Mok HY; Kim DE; Jung YH
Bioorg Med Chem; 2019 Aug; 27(15):3408-3420. PubMed ID: 31235266
[TBL] [Abstract][Full Text] [Related]
38. Selective Inhibition of Histone Deacetylase 10: Hydrogen Bonding to the Gatekeeper Residue is Implicated.
Géraldy M; Morgen M; Sehr P; Steimbach RR; Moi D; Ridinger J; Oehme I; Witt O; Malz M; Nogueira MS; Koch O; Gunkel N; Miller AK
J Med Chem; 2019 May; 62(9):4426-4443. PubMed ID: 30964290
[TBL] [Abstract][Full Text] [Related]
39. Acetylation/deacetylation and microtubule associated proteins influence flagellar axonemal stability and sperm motility.
Chawan V; Yevate S; Gajbhiye R; Kulkarni V; Parte P
Biosci Rep; 2020 Dec; 40(12):. PubMed ID: 33200789
[TBL] [Abstract][Full Text] [Related]
40. Dual targeted 2-Benzylideneindanone pendant hydroxamic acid group exhibits selective HDAC6 inhibition along with tubulin stabilization effect.
Kumar K; Das R; Thapa B; Rakhecha B; Srivastava S; Savita K; Israr M; Chanda D; Banerjee D; Shanker K; Bawankule DU; Santini B; Di Paolo ML; Via LD; Passarella D; Negi AS
Bioorg Med Chem; 2023 May; 86():117300. PubMed ID: 37146520
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
